Volume 27, Number 12—December 2021
Dispatch
Increased Incidence of Melioidosis in Far North Queensland, Queensland, Australia, 1998–2019
Table 1
Variable | 1998–2002 | 2003–2007 | 2008–2011 | 2012–2015 | 2016–2019 | p value* |
---|---|---|---|---|---|---|
Far North Queensland population, mean | 220,814 | 232,598 | 256,852 | 272,055 | 283,178 | <0.001 |
No. cases | 44 | 41 | 31 | 56 | 112 | <0.001 |
Annual incidence, cases/100,000 population, mean (95% CI) | 4.0 (2.7–5.2) | 3.5 (1.8–5.2) | 3.0 (0–6.2) | 5.1 (0.6–9.7) | 9.9 (4.9–14.9) | <0.001 |
Age, y, median (interquartile range) |
46 (32–58) |
52 (40–63) |
51 (38–62) |
49 (42–64) |
55 (47–65) |
0.001 |
Predisposing condition, % | ||||||
Any† | 73 | 85 | 84 | 82 | 90 | 0.02 |
Diabetes mellitus | 50 | 56 | 58 | 44 | 58 | 0.59 |
Hazardous alcohol use | 34 | 39 | 45 | 46 | 31 | 0.60 |
Chronic lung disease | 7 | 12 | 16 | 14 | 16 | 0.13 |
Chronic kidney disease | 16 | 15 | 3 | 23 | 17 | 0.48 |
Immunosuppression |
7 |
12 |
16 |
20 |
13 |
0.21 |
Bacteremia, % | 70 | 68 | 77 | 77 | 68 | 0.85 |
Case-fatality rate, % | 27 | 15 | 3 | 11 | 9 | 0.004 |
*p value for trend calculated by using annual data with year as a continuous variable. †Incomplete access to patient charts from early in the study period is likely to lead to overestimation of the proportion of cases with no predisposing factor.
Page created: October 06, 2021
Page updated: November 19, 2021
Page reviewed: November 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.